Translink Corporate Finance announces the IPO of FIT Biotech Oy, a Finnish biopharma company which develops and licenses its proprietary, patented Gene Transport Unit (GTU®) vector technology for new generation medical treatments. GTU is a gene transport technology that solves medical challenges in usability of gene therapy based treatments and DNA vaccines.